Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug

Lars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.

...

The 'special relationship' under pressure: Are Biden and Netanyahu on a collision course over Gaza?

1 week ago

Salesforce's behind-the-scenes co-founder is tackling Slack as software company turns 25

6 days ago

McDonald’s and other restaurant chains look to the Sun Belt for growth as population soars

6 days ago

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know

5 days ago

Nvidia's terrible Friday gives traders a preview of what a momentum unwind would look like

6 days ago